Phase I and pharmacologic study of the alkylating agent modulator novobiocin in combination with high-dose chemotherapy for the treatment of metastatic breast cancer (Q40986509)

From Wikidata
Jump to navigation Jump to search
scientific article published on May 1995
edit
Language Label Description Also known as
English
Phase I and pharmacologic study of the alkylating agent modulator novobiocin in combination with high-dose chemotherapy for the treatment of metastatic breast cancer
scientific article published on May 1995

    Statements

    Phase I and pharmacologic study of the alkylating agent modulator novobiocin in combination with high-dose chemotherapy for the treatment of metastatic breast cancer (English)
    M J Kennedy
    D K Armstrong
    A M Huelskamp
    K Ohly
    B V Clarke
    O M Colvin
    L B Grochow
    T L Chen
    N E Davidson
    1 May 1995
    1136-1143

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit